Page 8 - Domestic Markets

MTNL drops over 2% after Q4 net loss widens; down 12% in three months

MTNL's net loss widened to Rs 783.7 crore on a year-on-year (Y-o-Y) basis, from a net loss of Rs 748.6 crore in the fourth quarter of financial year 2023 (Q4FY23)

Why are DIIs buying heavily ahead of Lok Sabha elections? Analysts weigh in

Between January and May 28, DIIs have purchased shares worth Rs 1.97 trillion. In May alone, DIIs bought shares worth Rs 44,952.16 crore

Vedanta, Cochin Shipyard, JSPL among five stocks to track on May 14

Vedanta board will consider and approve the first Interim dividend on equity shares, if any, for the FY25, on May 16.

Before global scrutiny, Indian spice maker MDH faced several US rejections

Hong Kong suspended sales last month of three spice blends made by MDH and one by another Indian company, Everest, for apparently containing high levels of a cancer-causing pesticide

Stocks to Buy: Here's why Anand Rathi suggests HAL, Titan, Aegis Logistics

Since reaching its peak around the Rs 3,800 mark on April 1, 2024, the market has experienced a significant downturn, with a decline of nearly 600 points, translating to a 16 per cent loss in price

Stock Market Highlights, May 8: Benchmarks end flat after choppy session; Mid, SmallCap indices rise

Stock Market Highlights on May 8: The S&P BSE Sensex, after gyrating 611 points intraday, ended at 73,466, down 45 points. The Nifty, on the other hand, settled unchanged at 22,303

Spice row: Govt plans greater scrutiny, guidelines on use of ethylene oxide

ETO, a flammable, colourless gas is generally used as a disinfectant, sterilising agent as well as an insecticide to reduce microbial contamination in spices

FPIs domiciled at GIFT City allowed to issue P-notes to investors

Move could boost issuance and drive flows into domestic markets, say experts

Pre-election rally has more legs; stay cautious in small-caps: Apurva Sheth

The Sensex to SmallCap ratio is trading near its lowest levels since 2008. This means that smallcaps have outperformed relative to large-caps, Apurva Sheth said in this interview

RIL to boost homegrown Wyzr brand in Indian consumer electronics market

Mukesh Ambani's company aims to open its own manufacturing plants, expanding Wyzr's product range to include TVs, washing machines, refrigerators

Markets to focus on Budget, US Fed policy in eventful week, say analysts

Interim budget, the US Federal policy decision and quarterly earnings will be the major drivers for stock markets which may also see some consolidation this week, say analysts. Besides, investors would also focus on the trading activity of foreign investors and global trends for further cues. From the macroeconomic front, the PMI (Purchasing Managers' Index) data for the manufacturing sector is scheduled to be announced on Thursday. Finance Minister Nirmala Sitharaman will present the interim budget for 2024-25 on February 1 (Thursday). The Federal Open Market Committee meeting will be held on January 30 and 31. "Market is likely to consolidate further ahead of the US Fed interest rate decision where the Fed is expected to maintain status quo and give some hint with regards to rate cut timeline. Apart from this, BoE (Bank of England) monetary policy is also due coupled with a few key economic data releases which might keep markets volatile. "Further many heavyweights would be ...

Zero-duty unrefined gold imports take the shine off local players

Some refineries stayed away from giving an undertaking to govt. for not importing unrefined gold from LDCs

Markets soar on dovish US Federal Reserve, Sensex settles atop 70K

US 10-yr treasury yield now below 4% as risk appetite increases

Key overhang removed, focus to shift on earnings, liquidity: Brokerages

Results give message of political continuity and 'augur well' for macroeconomics, say brokerages

Vanguard to Goldman Sachs, global firms rush to buy Alipay's Zomato stakes

Shares of Zomato have nearly doubled this year as the company started to turn a profit after going public in 2021, prompting some of its biggest investors to lock in gains on their investments

Medicines for four rare diseases become cheaper due to domestic production

Medicines for four rare diseases have become available at drastically cheaper rates as Indian pharma companies are now producing them reducing the reliance on expensive imported formulations, Union Health Ministry officials said on Friday. The slashing of prices comes as the ministry has prioritised action related to 13 rare diseases along with sickle cell anaemia. Drugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with sickle cell Anemia have been approved and are being manufactured indigenously. Four more drugs for three diseases - Tablet Sapropterin for Phenylketonuria, tab Sodium Phenyl Butyrate and tablet Carglumic Acid for Hyperammonemia and Capsule Miglustat for Gaucher's disease - are under process for approval and are likely to be available by April 2024, official sources said. With these drugs being manufactured indigenously, the annual cost of Nitisinone capsules, used in the treatment of .

Markets rise for 3rd day as bond yields soften; Sensex, Nifty up nearly 1%

The Fed's dovish comments rekindled hopes of its rate-hiking campaign ending and spurred an equity rally across the globe

Markets rebound after Fed holds rates steady; Sensex rises 490 points

US bond yields retreat on signs the Federal Reserve may be done with tightening

A tidal wave of capital

With India poised to see a surge in domestic market inflows, the focus must shift to maximising the benefits for the economy

Manufacturing sentiment positive in first quarter, shows Ficci survey

In the fourth quarter of FY23, 55 per cent of the respondents reported higher production levels